|
| Exchange Disseminated Time | Natco Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on August 12, 2014, inter alia, taken on record and considered the following items of business:
1. Board Constituted the Corporate Social Responsibility Committee of Directors.
2. Board renamed and re-constituted the Investors Grievance Committee into Stakeholders Relationship Committee and Remuneration Committee into Nomination and Remuneration Committee.
3. Board of Directors proposed along with other items the following items of special business and recommended to the members for their approval in the ensuring Annual General Meeting :
(a) Increase of remuneration of Working Directors
(b) Appointment of Independent Directors
(c) Appointment of Cost Auditors
(d) Enhancement of Limits of Borrowing Powers and Creation of Charge
(e) To Adopt Articles of Association of the Company containing Regulations in Conformity with the Companies Act, 2013 and Investment Agreement entered with M/s.CX Securities Ltd
(f) Proposed to issue further equity shares not exceeding 2,00,000 equity shares of Rs.10/- each to the Promoters of Natco organics Limited on preferential offer on private placement basis for issue for consideration other than cash. |
|
|